Johnson & Johnson (JNJ) Gets a Buy from Citi
I'm LongbridgeAI, I can summarize articles.Citi analyst Joanne Wuensch maintained a Buy rating on Johnson & Johnson (JNJ), whose shares closed at $254.93. This follows a similar Buy recommendation from Scotiabank's Louise Chen. Conversely, Bank of America Securities reiterated a Hold rating on the stock on July 28.
Citi analyst Joanne Wuensch maintained a Buy rating on Johnson & Johnson yesterday. The company’s shares closed yesterday at $254.93.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Wuensch covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Integra Lifesciences, and Baxter International. According to TipRanks, Wuensch has an average return of 1.8% and a 53.74% success rate on recommended stocks.
In addition to Citi, Johnson & Johnson also received a Buy from Scotiabank’s Louise Chen in a report issued yesterday. However, on July 28, Bank of America Securities reiterated a Hold rating on Johnson & Johnson (NYSE: JNJ).